Endoluminal Vacuum Therapy as Effective Treatment for Patients with Postoperative Leakage After Metabolic Bariatric Surgery-A Single-Center Experience.

Bariatric surgery Endoluminal vacuum therapy RYGB Revisional surgery

Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
24 Jul 2024
Historique:
received: 04 03 2024
accepted: 14 06 2024
revised: 09 06 2024
medline: 24 7 2024
pubmed: 24 7 2024
entrez: 24 7 2024
Statut: aheadofprint

Résumé

Metabolic bariatric surgery (MBS) is standardized and safe. Nevertheless, complications such as anastomotic leakage (AL) or staple-line leakage (SLL) can occur. In upper GI or colorectal surgery, endoluminal vacuum therapy (EVT) offers a therapeutic alternative to revisional surgery. Data on EVT in patients with leakage after MBS remain scarce. The aim of this study is to evaluate the efficacy of EVT and its potential as endoscopic alternative to revisional surgery. All patients treated for AL or SLL with EVT after MBS between 01/2016 and 08/2023 at the Department for General Surgery, Medical University Vienna, were included in this retrospective, single-center study. Therapeutic value of EVT as management option for acute postoperative leakage after MBS in daily practice was evaluated. Statistical analyses were performed descriptively. Twenty-one patients were treated with EVT within the observational period of 7 years. In 11 cases (52.4%), the index surgery was a primary bariatric intervention; in 10 cases (47.6%), a secondary surgery after initial MBS was performed. Favored approach was a combination of revisional surgery and EVT (n = 18; 85.7%), intermediate self-expanding metal stent (SEMS) in 16 (76.2%) cases. EVT was changed six times (0-33) every 3-4 days. Mean EVT time was 25.1 days (3-97). No severe associated complications were detected and EVT showed an efficacy of 95.2%. This small case series supports the trend to establish EVT in daily clinical practice when revisional surgery after MBS is needed, thus preventing further reoperation and reducing associated morbidity and mortality in critically ill patients.

Sections du résumé

BACKGROUND BACKGROUND
Metabolic bariatric surgery (MBS) is standardized and safe. Nevertheless, complications such as anastomotic leakage (AL) or staple-line leakage (SLL) can occur. In upper GI or colorectal surgery, endoluminal vacuum therapy (EVT) offers a therapeutic alternative to revisional surgery. Data on EVT in patients with leakage after MBS remain scarce. The aim of this study is to evaluate the efficacy of EVT and its potential as endoscopic alternative to revisional surgery.
MATERIAL AND METHODS METHODS
All patients treated for AL or SLL with EVT after MBS between 01/2016 and 08/2023 at the Department for General Surgery, Medical University Vienna, were included in this retrospective, single-center study. Therapeutic value of EVT as management option for acute postoperative leakage after MBS in daily practice was evaluated. Statistical analyses were performed descriptively.
RESULTS RESULTS
Twenty-one patients were treated with EVT within the observational period of 7 years. In 11 cases (52.4%), the index surgery was a primary bariatric intervention; in 10 cases (47.6%), a secondary surgery after initial MBS was performed. Favored approach was a combination of revisional surgery and EVT (n = 18; 85.7%), intermediate self-expanding metal stent (SEMS) in 16 (76.2%) cases. EVT was changed six times (0-33) every 3-4 days. Mean EVT time was 25.1 days (3-97). No severe associated complications were detected and EVT showed an efficacy of 95.2%.
CONCLUSION CONCLUSIONS
This small case series supports the trend to establish EVT in daily clinical practice when revisional surgery after MBS is needed, thus preventing further reoperation and reducing associated morbidity and mortality in critically ill patients.

Identifiants

pubmed: 39046624
doi: 10.1007/s11695-024-07367-2
pii: 10.1007/s11695-024-07367-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Felsenreich DM, Artemiou E, Steinlechner K, et al. Fifteen years after sleeve gastrectomy: weight loss, remission of associated medical problems, quality of life, and conversions to Roux-en-Y gastric bypass-long-term follow-up in a multicenter study. Obes Surg. 2021;31(8):3453–61.
doi: 10.1007/s11695-021-05475-x pubmed: 34021882 pmcid: 8270807
Felsenreich DM, Artemiou E, Wintersteller L, et al. Fifteen years after sleeve gastrectomy: gastroscopies, manometries, and 24-h pH-metries in a long-term follow-up: a multicenter study. Obes Facts. 2022;15(5):666–73.
doi: 10.1159/000526170 pubmed: 35882187 pmcid: 9669976
Huppler L, Robertson AG, Wiggins T, et al. How safe bariatric surgery is-an update on perioperative mortality for clinicians and patients. Clin Obes. 2022;12(3):e12515.
doi: 10.1111/cob.12515 pubmed: 35261160
Gero D, Vannijvel M, Okkema S, et al. Defining global benchmarks in elective secondary bariatric surgery comprising conversional, revisional, and reversal procedures. Ann Surg. 2021;274(5):821–8.
doi: 10.1097/SLA.0000000000005117 pubmed: 34334637
Aminian A, Al-Kurd A, Wilson R, et al. Association of bariatric surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis. JAMA. 2021;326(20):2031–42.
doi: 10.1001/jama.2021.19569 pubmed: 34762106 pmcid: 8587225
Beiglbock H, Morth E, Reichardt B, et al. Sex-specific differences in mortality of patients with a history of bariatric surgery: a nation-wide population-based study. Obes Surg. 2022;32(1):8–17.
doi: 10.1007/s11695-021-05763-6 pubmed: 34751909
Carlsson LM, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367(8):695–704.
doi: 10.1056/NEJMoa1112082 pubmed: 22913680
Carrasquilla C, English WJ, Esposito P, et al. Total stapled, total intra-abdominal (TSTI) laparoscopic Roux-en-Y gastric bypass: one leak in 1000 cases. Obes Surg. 2004;14(5):613–7.
doi: 10.1381/096089204323093372 pubmed: 15186627
Fernandez Jr AZ, DeMaria EJ, Tichansky DS, et al. Experience with over 3,000 open and laparoscopic bariatric procedures: multivariate analysis of factors related to leak and resultant mortality. Surg Endosc. 2004;18(2):193–7.
doi: 10.1007/s00464-003-8926-y pubmed: 14691697
Fullum TM, Aluka KJ, Turner PL. Decreasing anastomotic and staple line leaks after laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2009;23(6):1403–8.
doi: 10.1007/s00464-009-0370-1 pubmed: 19263134
Puig CA, Waked TM, Baron Sr TH. Wong Kee Song LM, Gutierrez J, Sarr MG. The role of endoscopic stents in the management of chronic anastomotic and staple line leaks and chronic strictures after bariatric surgery. Surg Obes Relat Dis. 2014;10(4):613–7.
doi: 10.1016/j.soard.2013.12.018 pubmed: 24680763
Spota A, Cereatti F, Granieri S, et al. Endoscopic management of bariatric surgery complications according to a standardized algorithm. Obes Surg. 2021;31(10):4327–37.
doi: 10.1007/s11695-021-05577-6 pubmed: 34297256
El-Sourani N, Miftode S, Bockhorn M, et al. Endoscopic management of anastomotic leakage after esophageal surgery: ten year analysis in a tertiary university center. Clin Endosc. 2022;55(1):58–66.
doi: 10.5946/ce.2021.099 pubmed: 34645084
Gurwara S, Clayton S. Esophageal perforations: an endoscopic approach to management. Curr Gastroenterol Rep. 2019;21(11):57.
doi: 10.1007/s11894-019-0730-5 pubmed: 31749030
Hua F, Sun D, Zhao X, et al. Update on therapeutic strategy for esophageal anastomotic leak: a systematic literature review. Thorac Cancer. 2023;14(4):339–47.
doi: 10.1111/1759-7714.14734 pubmed: 36524684
Kuhn F, Schardey J, Wirth U, et al. Endoscopic vacuum therapy for the treatment of colorectal leaks - a systematic review and meta-analysis. Int J Colorectal Dis. 2022;37(2):283–92.
doi: 10.1007/s00384-021-04066-7 pubmed: 34817647
Intriago JMV, de Moura DTH, do Monte Junior ES, et al. Endoscopic vacuum therapy (EVT) for the treatment of post-bariatric surgery leaks and fistulas: a systematic review and meta-analysis. Obes Surg. 2022;32(10):3435–51.
doi: 10.1007/s11695-022-06228-0 pubmed: 35918596
Rosenthal RJ, Diaz AA, Arvidsson D, et al. International Sleeve Gastrectomy Expert Panel Consensus Statement: best practice guidelines based on experience of >12,000 cases. Surg Obes Relat Dis. 2012;8(1):8–19.
doi: 10.1016/j.soard.2011.10.019 pubmed: 22248433
Archid R, Wichmann D, Klingert W, et al. Endoscopic vacuum therapy for staple line leaks after sleeve gastrectomy. Obes Surg. 2020;30(4):1310–5.
doi: 10.1007/s11695-019-04269-6 pubmed: 31792702
Takahashi H, Strong AT, Guerron AD, et al. An Odyssey of complications from band, to sleeve, to bypass; definitive laparoscopic completion gastrectomy with distal esophagectomy and esophagojejunostomy for persistent leak. Surg Endosc. 2018;32(1):507–10.
doi: 10.1007/s00464-017-5757-9 pubmed: 28726146
Aryaie AH, Singer JL, Fayezizadeh M, et al. Efficacy of endoscopic management of leak after foregut surgery with endoscopic covered self-expanding metal stents (SEMS). Surg Endosc. 2017;31(2):612–7.
doi: 10.1007/s00464-016-5005-8 pubmed: 27317034
Hany M, Ibrahim M, Zidan A, et al. Role of primary use of mega stents alone and combined with other endoscopic procedures for early leak and stenosis after bariatric surgery, single-institution experience. Obes Surg. 2021;31(5):2050–61.
doi: 10.1007/s11695-020-05211-x pubmed: 33409972
Markus A, Henrik BJ, Benedikt R, et al. Endoscopic vacuum therapy in salvage and standalone treatment of gastric leaks after bariatric surgery. Langenbecks Arch Surg. 2022;407(3):1039–46.
doi: 10.1007/s00423-021-02365-9 pubmed: 34787705
Schmidt F, Mennigen R, Vowinkel T, et al. Endoscopic vacuum therapy (EVT)-a new concept for complication management in bariatric surgery. Obes Surg. 2017;27(9):2499–505.
doi: 10.1007/s11695-017-2783-6 pubmed: 28695459
Klose MA, Walldorf J, Damm M, et al. Treatment of esophageal leakages with the Microtech((R))-VAC-Stent: a monocentric early experience of three cases. Ther Adv Gastrointest Endosc. 2023;16:26317745231200312.
doi: 10.1177/26317745231200312 pubmed: 37779920 pmcid: 10540572
Al Zoubi M, Khidir N, Bashah M. Challenges in the diagnosis of leak after sleeve gastrectomy: clinical presentation, laboratory, and radiological findings. Obes Surg. 2021;31(2):612–6.
doi: 10.1007/s11695-020-05008-y pubmed: 33025538

Auteurs

L Gensthaler (L)

Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

M Stauffer (M)

Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

J Jedamzik (J)

Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

C Bichler (C)

Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

L Nixdorf (L)

Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

P Richwien (P)

Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

J Eichelter (J)

Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

F B Langer (FB)

Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

G Prager (G)

Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. gerhard.prager@meduniwien.ac.at.

D M Felsenreich (DM)

Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

Classifications MeSH